Skip to main content
. 2011 Feb 4;84(2):255–260. doi: 10.4269/ajtmh.2011.10-0155

Figure 1.

Figure 1.

Relapse in a patient with cutaneous leishmaniasis (CL) treated with miltefosine (A), classified intially as apparent cure with complete lesion epithelialization (B) but relapse at the second month follow-up visit – recidiva cutis (C and D). Note the nodular lesions in C and D.